Another uninformative response
The Directors of the Company refer ASX to its recent letter of 3 October 2018. The Directors of the Company reiterate the matters therein set out, and believe that the recent increase in the share price and volume may be attributable to the matters referred to in that earlier letter (and, in particular, to the Company’s announcements to ASX of 13 September and 24 September 2018 and the expiration of the EDEO options on 30 September 2018). The Company also notes that the shares of the Company have traded at significantly higher prices in the last 12 months than they are currently trading: on 3 October 2017 the Company’s share price was 18 cents, and during that 12 month period, the Company has made significant progress with the commercialisation of its EdenCrete® admixture. It also appears to the Company, from a general review of its recent trading history, that in excess of 50% of the daily trading volume during the past week has been by day traders (who are buying and selling shares on the same day), and which transactions do not even appear on the net daily changes on the Company’s share register.
- Forums
- ASX - By Stock
- EDE
- Ann: ASX Price and Volume Query Response
Ann: ASX Price and Volume Query Response, page-3
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EDE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.216M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
EDE (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online